Not recruiting yet
A Real-World Case Study Evaluating the Efficacy and Safety of RBS Cryobiopsy
NCT06832930 · Guangzhou Medical University · Updated 18 Feb 2025
- What is being tested
- unicorn robotic bronchoscopy system; Conventional navigation bronchoscopy
- For
- Peripheral Pulmonary Lesion
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years to 75 years. About 200 people. The full rules are on the registry page.
- Where
- Not stated
- When
- Starts or started 15 Feb 2025, ends 31 Dec 2025. Registered 18 Feb 2025.
- Results
- None posted yet.
In the researchers' words
The goal of this clinical trial is tois to assess the effectiveness and safety of RBS (Robotic Bronchoscopy System)-assisted cryobiopsy in real-world clinical settings in adult patients (aged ≥18 years) with suspected pulmonary lesions requiring diagnostic bronchoscopic evaluation. The main questions it aims to answer are: Does RBS-assisted cryobiopsy improve diagnostic yield compared to conventional non-RBS-guided cryobiopsy? Is RBS-assisted cryobiopsy associated with a lower incidence of procedure-related complications (e.g., bleeding, pneumothorax) compared to conventional methods? Researchers will compare the RBS group (patients undergoing RBS-assisted cryobiopsy) with the control group (patients undergoing cryobiopsy with conventional navigation techniques, such as ENB, VBN) to evaluate differences in diagnostic accuracy and safety outcomes. Participants will: Provide informed consent for bronchoscopic cryobiopsy. Undergo pre-procedure imaging and clinical evaluation. Receive either RBS-assisted or conventional cryobiopsy based on clinical indication and operator discretion. Be monitored for immediate and delayed complications .